Patented & Tested
A promising treatment for Alzheimer’s
(and other age-related neurological ailments) has been invented by a
a
Russian scientist and is about to be
formally announced by Buddha Biopharma OY (BB), Finland.
The treatment involves the nasal
administration of dicholine succinate.
The technology is protected by U.S.
patents.
Tests on animals have been
successfully completed!
The permissions to test this medical
technology on humans has been received.
Small Investment,
Large Equity
The investment required to complete
the technology commercialization process is minuscule, in light of
the upside an effective treatment, and potential prevention, of
Alzheimer’s promises.
A significant equity is offered
to a investor!
